Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
herpes
Manufacturing
Manufacturing issues prompt FDA rejection of Hyloris antiviral
The FDA has rejected Hyloris' antiviral valacyclovir, an oral suspension for infections caused by herpes simplex, because of manufacturing issues.
Kevin Dunleavy
Mar 13, 2026 8:40am
FDA launches criminal investigation into rogue herpes vaccine research
Apr 12, 2018 9:25am
Participants in rogue herpes vaccine research take legal action
Mar 14, 2018 8:55am
Herpes researcher experiments on people before heading abroad
Nov 27, 2017 9:54am
Peter Thiel backs unregulated offshore herpes vaccine trial
Aug 29, 2017 10:00am
